Cargando…
A Simple and Cost-Efficient Platform for a Novel Porcine Circovirus Type 2d (PCV2d) Vaccine Manufacturing
Porcine circovirus type 2d (PCV2d) is becoming the predominant PCV genotype and considerably affects the global pig industry. Nevertheless, currently, no commercial PCV2d vaccine is available. Preventing and controlling the disease caused by PCV2d is therefore based on other genotype-based vaccines....
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865830/ https://www.ncbi.nlm.nih.gov/pubmed/36680014 http://dx.doi.org/10.3390/vaccines11010169 |
_version_ | 1784875936561233920 |
---|---|
author | Noppiboon, Sarawuth Lapanusorn, Neeracha Ekkpongpaisit, Pisit Slack, Sarah Frank, Stefanie Hocharoen, Lalintip |
author_facet | Noppiboon, Sarawuth Lapanusorn, Neeracha Ekkpongpaisit, Pisit Slack, Sarah Frank, Stefanie Hocharoen, Lalintip |
author_sort | Noppiboon, Sarawuth |
collection | PubMed |
description | Porcine circovirus type 2d (PCV2d) is becoming the predominant PCV genotype and considerably affects the global pig industry. Nevertheless, currently, no commercial PCV2d vaccine is available. Preventing and controlling the disease caused by PCV2d is therefore based on other genotype-based vaccines. However, their production platforms are laborious, limited in expression level, and relatively expensive for veterinary applications. To address these challenges, we have developed a simple and cost-efficient platform for a novel PCV2d vaccine production process, using fed-batch E. coli fermentation followed by cell disruption and filtration, and a single purification step via cation exchange chromatography. The process was developed at bench scale and then pilot scale, where the PCV2d subunit protein yield was approximately 0.93 g/L fermentation volume in a short production time. Moreover, we have successfully implemented this production process at two different sites, in Southeast Asia and Europe. This demonstrates transferability and the high potential for successful industrial production. |
format | Online Article Text |
id | pubmed-9865830 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98658302023-01-22 A Simple and Cost-Efficient Platform for a Novel Porcine Circovirus Type 2d (PCV2d) Vaccine Manufacturing Noppiboon, Sarawuth Lapanusorn, Neeracha Ekkpongpaisit, Pisit Slack, Sarah Frank, Stefanie Hocharoen, Lalintip Vaccines (Basel) Article Porcine circovirus type 2d (PCV2d) is becoming the predominant PCV genotype and considerably affects the global pig industry. Nevertheless, currently, no commercial PCV2d vaccine is available. Preventing and controlling the disease caused by PCV2d is therefore based on other genotype-based vaccines. However, their production platforms are laborious, limited in expression level, and relatively expensive for veterinary applications. To address these challenges, we have developed a simple and cost-efficient platform for a novel PCV2d vaccine production process, using fed-batch E. coli fermentation followed by cell disruption and filtration, and a single purification step via cation exchange chromatography. The process was developed at bench scale and then pilot scale, where the PCV2d subunit protein yield was approximately 0.93 g/L fermentation volume in a short production time. Moreover, we have successfully implemented this production process at two different sites, in Southeast Asia and Europe. This demonstrates transferability and the high potential for successful industrial production. MDPI 2023-01-12 /pmc/articles/PMC9865830/ /pubmed/36680014 http://dx.doi.org/10.3390/vaccines11010169 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Noppiboon, Sarawuth Lapanusorn, Neeracha Ekkpongpaisit, Pisit Slack, Sarah Frank, Stefanie Hocharoen, Lalintip A Simple and Cost-Efficient Platform for a Novel Porcine Circovirus Type 2d (PCV2d) Vaccine Manufacturing |
title | A Simple and Cost-Efficient Platform for a Novel Porcine Circovirus Type 2d (PCV2d) Vaccine Manufacturing |
title_full | A Simple and Cost-Efficient Platform for a Novel Porcine Circovirus Type 2d (PCV2d) Vaccine Manufacturing |
title_fullStr | A Simple and Cost-Efficient Platform for a Novel Porcine Circovirus Type 2d (PCV2d) Vaccine Manufacturing |
title_full_unstemmed | A Simple and Cost-Efficient Platform for a Novel Porcine Circovirus Type 2d (PCV2d) Vaccine Manufacturing |
title_short | A Simple and Cost-Efficient Platform for a Novel Porcine Circovirus Type 2d (PCV2d) Vaccine Manufacturing |
title_sort | simple and cost-efficient platform for a novel porcine circovirus type 2d (pcv2d) vaccine manufacturing |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865830/ https://www.ncbi.nlm.nih.gov/pubmed/36680014 http://dx.doi.org/10.3390/vaccines11010169 |
work_keys_str_mv | AT noppiboonsarawuth asimpleandcostefficientplatformforanovelporcinecircovirustype2dpcv2dvaccinemanufacturing AT lapanusornneeracha asimpleandcostefficientplatformforanovelporcinecircovirustype2dpcv2dvaccinemanufacturing AT ekkpongpaisitpisit asimpleandcostefficientplatformforanovelporcinecircovirustype2dpcv2dvaccinemanufacturing AT slacksarah asimpleandcostefficientplatformforanovelporcinecircovirustype2dpcv2dvaccinemanufacturing AT frankstefanie asimpleandcostefficientplatformforanovelporcinecircovirustype2dpcv2dvaccinemanufacturing AT hocharoenlalintip asimpleandcostefficientplatformforanovelporcinecircovirustype2dpcv2dvaccinemanufacturing AT noppiboonsarawuth simpleandcostefficientplatformforanovelporcinecircovirustype2dpcv2dvaccinemanufacturing AT lapanusornneeracha simpleandcostefficientplatformforanovelporcinecircovirustype2dpcv2dvaccinemanufacturing AT ekkpongpaisitpisit simpleandcostefficientplatformforanovelporcinecircovirustype2dpcv2dvaccinemanufacturing AT slacksarah simpleandcostefficientplatformforanovelporcinecircovirustype2dpcv2dvaccinemanufacturing AT frankstefanie simpleandcostefficientplatformforanovelporcinecircovirustype2dpcv2dvaccinemanufacturing AT hocharoenlalintip simpleandcostefficientplatformforanovelporcinecircovirustype2dpcv2dvaccinemanufacturing |